β-Lactam/β-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials

T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam

(2013) Fausto Catena et al.   BMC GASTROENTEROLOGY

Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan

(2013) Yoshihiro Yamamoto et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study

(2012) José A. Vazquez et al.   CURRENT MEDICAL RESEARCH AND OPINION

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum  -lactamases: a systematic review and meta-analysis

(2012) K. Z. Vardakas et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK

(2012) N. H. Wickramasinghe et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fecal Carriage of ESBL-Producing E. coli and K. pneumoniae in Children in Guinea-Bissau: A Hospital-Based Cross-Sectional Study

(2012) Joakim Isendahl et al.   PLoS One

 -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum  -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts

(2011) J. Rodriguez-Bano et al.   CLINICAL INFECTIOUS DISEASES

Prevalence and characterisation of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates in healthy volunteers in Tunisia

(2011) R. Ben Sallem et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden

(2011) H. Strömdahl et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Comparison of Sulbactam-Cefoperazone with Carbapenems as Empirical Monotherapy for Febrile Neutropenic Children with Lymphoma and Solid Tumors

(2011) Hacı Ahmet Demir et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Piperacillin-tazobactam Versus Carbapenem Therapy With and Without Amikacin as Empirical Treatment of Febrile Neutropenia in Cancer Patients: Results of an Open Randomized Trial at a University Hospital

(2010) N. Oztoprak et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: Comparison with imipenem/cilastatin

(2010) Isao Ito et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Piperacillin/tazobactam versus imipenem/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital

(2009) N. Saltoglu et al.   CLINICAL MICROBIOLOGY AND INFECTION

Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia

(2009) Sema Vural et al.   PEDIATRICS INTERNATIONAL

Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study

(2008) Álvaro Réa-Neto et al.   CURRENT MEDICAL RESEARCH AND OPINION